IL-17 in obesity and adipogenesis

Area of Science:

• Immunology
• Metabolic disease research
• Cell biology

Background:

• Interleukin-17 (IL-17) is a pro-inflammatory cytokine implicated in tissue inflammation.
• Obesity is characterized by chronic low-grade inflammation, suggesting a potential role for IL-17 in adipose tissue.
• The specific role of IL-17 in obesity remains largely unexplored, despite its association with inflammation.

Purpose of the Study:

• To consolidate current understanding of IL-17's implications in obesity.
• To review emerging data on the role of IL-17 within adipose tissue.
• To explore the complex interconnections between IL-17 and fat metabolism.

Main Methods:

• Literature review of emerging studies on IL-17 and obesity.
• Analysis of murine models of autoimmunity (EAE, colitis) involving Th17 cells.
• Examination of human clinical studies reporting IL-17 levels in obese individuals.

Main Results:

• Obesity promotes the expansion of the Th17 T-cell lineage, potentially exacerbating inflammatory conditions.
• Elevated IL-17 levels have been observed in obese human populations.
• Evidence suggests IL-17 may possess anti-adipogenic properties, indicating a complex role in fat metabolism.

Conclusions:

• IL-17's role in obesity is multifaceted, involving both pro-inflammatory and potentially anti-adipogenic effects.
• Further research is needed to fully elucidate the intricate relationship between IL-17, adipose tissue, and metabolic health.
• Understanding IL-17's impact on fat metabolism is crucial for developing targeted obesity interventions.